Breaking News, Collaborations & Alliances

Getinge Acquires High Purity New England

Acquisition will expand Getinge’s presence in the biopharma segment.

Getinge, a company that provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows, will acquire 100% of the shares in High Purity New England, Inc. (HPNE), a company involved in custom single-use solutions for bioprocessing applications. Under terms of the deal, Getinge will acquire all outstanding shares from the shareholders of HPNE and will pay approximately $120 million. The transaction is expected to close in ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters